Hidradenitis suppurativa – biologic therapy and other available treatment options

Katarzyna Lipa; Natalia Zając; Grzegorz Witkowski; Piotr Ciechanowicz; Kacper Wiszniewski; Elżbieta Szymańska; Irena Walecka

doi:10.5114/ada.2021.112075

eISSN: 2299-0046
ISSN: 1642-395X

Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii

Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

4/2023
vol. 40

Send email

Copy url:

abstract:

Review paper

Hidradenitis suppurativa – biologic therapy and other available treatment options

Katarzyna Lipa

¹

,

Natalia Zając

¹

,

Grzegorz Witkowski

²

,

Piotr Ciechanowicz

¹

,

Kacper Wiszniewski

¹

,

Elżbieta Szymańska

¹

,

Irena Walecka

¹

Department of Dermatology, Centre of Postgraduate Medical Education/Central Clinical Hospital MSWiA, Warsaw, Poland
Department of Gastroenterological Surgery and Transplantation Medicine, Centre of Postgraduate Medical Education/Central Clinical Hospital MSWiA, Warsaw, Poland

Adv Dermatol Allergol 2023; XL (4): 518-528

DOI: https://doi.org/10.5114/ada.2021.112075

Online publish date: 2022/01/18

View full text Get citation

EndNote

Papers, Reference Manager, RefWorks, Zotero

AMA

Lipa K, Zając N, Witkowski G, et al. Hidradenitis suppurativa – biologic therapy and other available treatment options. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2023;40(4):518-528. doi:10.5114/ada.2021.112075.

APA

Lipa, K., Zając, N., Witkowski, G., Ciechanowicz, P., Wiszniewski, K.,  & Szymańska, E. et al. (2023). Hidradenitis suppurativa – biologic therapy and other available treatment options. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, 40(4), 518-528. https://doi.org/10.5114/ada.2021.112075

Chicago

Lipa, Katarzyna, Natalia Zając, Grzegorz Witkowski, Piotr Ciechanowicz, Kacper Wiszniewski, Elżbieta Szymańska,  and Irena Walecka. 2023. "Hidradenitis suppurativa – biologic therapy and other available treatment options". Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii 40 (4): 518-528. doi:10.5114/ada.2021.112075.

Harvard

Lipa, K., Zając, N., Witkowski, G., Ciechanowicz, P., Wiszniewski, K., Szymańska, E.,  and Walecka, I. (2023). Hidradenitis suppurativa – biologic therapy and other available treatment options. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, 40(4), pp.518-528. https://doi.org/10.5114/ada.2021.112075

MLA

Lipa, Katarzyna et al. "Hidradenitis suppurativa – biologic therapy and other available treatment options." Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, vol. 40, no. 4, 2023, pp. 518-528. doi:10.5114/ada.2021.112075.

Vancouver

Lipa K, Zając N, Witkowski G, Ciechanowicz P, Wiszniewski K, Szymańska E et al. Hidradenitis suppurativa – biologic therapy and other available treatment options. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2023;40(4):518-528. doi:10.5114/ada.2021.112075.

Hidradenitis suppurativa (HS) is a chronic recurrent inflammatory skin disease that is characterized by painful, recurrent nodules and abscesses. The overall prevalence of HS is estimated to be 11 per 100,000 individuals in the United States and 4% of the world’s population. Women are 3 times more affected than men, especially patients between 18 and 29 years of age. Similarly to acne vulgaris, HS is primarily associated with follicular occlusion, which results from a number of biological processes, including follicular epithelial hyperplasia and hyperkeratinisation. There are numerous available treatment options for cutaneous lesions in the course of HS. A combination of conservative therapy and appropriate surgical treatment conducted by an experienced surgeon ensures the best possible clinical outcomes. Presently, biologic therapy is the most effective pharmacological treatment in patients with moderate to severe course of the disease. Numerous ongoing clinical trials provide hope for greater availability of new biologic therapy methods.

keywords:

Hidradenitis suppurativa – biologic therapy and other available treatment options

Katarzyna Lipa 1 , Natalia Zając 1 , Grzegorz Witkowski 2 , Piotr Ciechanowicz 1 , Kacper Wiszniewski 1 , Elżbieta Szymańska 1 , Irena Walecka 1

hidradenitis suppurativa, dermatology, abscesses, scarring, biological treatment

Katarzyna Lipa

¹

,

Natalia Zając

¹

,

Grzegorz Witkowski

²

,

Piotr Ciechanowicz

¹

,

Kacper Wiszniewski

¹

,

Elżbieta Szymańska

¹

,

Irena Walecka

¹